comparemela.com

Latest Breaking News On - Jubilant therapeutics - Page 1 : comparemela.com

Jubilant Therapeutics Inc. Appoints Nadir Patel as an Independent Member of Its Board of Directors

/PRNewswire/ Jubilant Therapeutics Inc., a clinical stage biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical.

BhutanIndiaBedminsterNew jerseyUnited statesNepalShanghaiChinaCanadaCanadianRepublic of indiaKingdom of bhutanHaris bhartiaHuron university atLondon school of economicsCanada department of foreign affairs

Jubilant Pharmova arm gets OAI status from USFDA for Montreal facility

The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.

KarnatakaIndiaMontrealQuebecCanadaNanjangudUnited statesJubilant life sciencesContract research developmentDrug administrationJubilant pharmovaJubilant hollisterstier general partnershipJubilant pharmova limitedContract manufacturingAction indicatedPharmova limited

Jubilant Therapeutics Inc.'s Selective, Orally Administered PAD4 Inhibitor Demonstrates Activity in Rheumatoid Arthritis Preclinical Models

/PRNewswire/ Jubilant Therapeutics Inc., a clinical stage biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical.

BedminsterNew jerseyUnited statesBostonMassachusettsDenisa wagnerLuca rastelliPrnewswire jubilant therapeutics incJubilant therapeutics incLinkedinBoston childrenTherapeutics incProtein arginine deiminaseRheumatoid arthritisScientific reportsChief scientific officer

FDA news: Lymphoma, multiple myeloma drugs receive fast track designation

The FDA announced several regulatory actions the past few weeks. Here is an overview of decisions that may be relevant to your practice.

WashingtonUnited statesMindy valcarcelArtiva biotherapeuticsPfizerJubilant therapeuticsSpringworks therapeutics

Jubilant Therapeutics Inc. receives Orphan Drug Designation for JBI-802 for Acute Myeloid Leukemia (AML) and Small Cell Lung Cancer (SCLC)

/PRNewswire/ Jubilant Therapeutics Inc., a clinical stage biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical.

United statesNew jerseyBedminsterSyed kazmiLinkedinPrnewswire jubilant therapeutics incDrug administrationJubilant therapeutics incOffice of orphan products developmentTherapeutics incUnited states foodOrphan drug designationTherapeutic indexBrain exposure optimizationOrphan drug designationsChief executive officer

vimarsana © 2020. All Rights Reserved.